Sponsor or institution

Clinical trials and research at The Children's Hospital of Zhejiang University School of Medicine

• 25Clinical trials
• 1Country

Newest trials

All recruiting trials (25)

• Ph+ ALL in Chinese Children: Diagnosis, Treatment, and Survival

  This study tests how children in China with Philadelphia chromosome–positive ALL are diagnosed, treated, and how long they survive in real-world practice.

  Recruiting The Children's Hospital of Zhejiang University School of Medicine · Hangzhou, Zhejiang · NCT07813208

• CD19/BCMA UCART for B cell–related autoimmune diseases

  This early-stage study tests QT-219CX, a universal allogeneic CAR-T cell therapy that targets CD19 and BCMA, in people with refractory B-cell–related autoimmune diseases to see if it can be given safely and provide early signs of benefit.

  Recruiting Early Phase 1 The Children's Hospital of Zhejiang University School of Medicine · Hangzhou, Zhejiang · NCT07586267

• Allogeneic CD19/BCMA CAR‑T for B‑cell autoimmune disease

  This Phase 1 study will test a donor-derived CAR‑T therapy that targets CD19 and BCMA to try to reset the immune system in people with refractory B‑cell autoimmune diseases such as SLE, IgA nephropathy, systemic sclerosis, and resistant nephrotic syndrome.

  Recruiting Early Phase 1 The Children's Hospital of Zhejiang University School of Medicine · Hangzhou, Zhejiang · NCT07507201

• Anti-CD19/BCMA CAR‑NK cell therapy for refractory pediatric rheumatic diseases

  This trial will test a single injection of engineered CAR‑NK cells aimed at CD19 and BCMA to see if it is safe and helps children aged 5 and older whose rheumatic diseases have not responded to other treatments.

  Recruiting Early Phase 1 The Children's Hospital of Zhejiang University School of Medicine · Hangzhou, Zhejiang · NCT07490041

• Tailoring allergy shots to a child's dust mite allergy profile

  This project will see if matching allergy shots to each child's specific dust mite proteins helps children ages 5–17 with dust mite nasal allergies (and well-controlled asthma) have fewer symptoms.

  Recruiting The Children's Hospital of Zhejiang University School of Medicine · Hangzhou, Zhejiang · NCT07452380

• Symptom patterns and gut bacteria in childhood cancer survivors

  This project will test whether groups of ongoing symptoms in childhood cancer survivors are linked to differences in gut bacteria and their metabolites.

  Recruiting The Children's Hospital of Zhejiang University School of Medicine · Hangzhou, Zhejiang · NCT07450872

• Immune profiling of children with cSLE receiving CD3×CD19 BiTE therapy

  We will try to map immune changes in children with childhood-onset systemic lupus erythematosus who are receiving CD3×CD19 bispecific T‑cell engager (BiTE) therapy.

  Recruiting The Children's Hospital of Zhejiang University School of Medicine · Hangzhou · NCT07352332

• Allogeneic CAR T cells targeting CD19 and BCMA for B‑cell autoimmune diseases

  This study will try a single infusion of off‑the‑shelf CAR T cells that target CD19 and BCMA to treat people with B‑cell–mediated autoimmune diseases such as lupus, IgA nephropathy, and drug‑resistant nephrotic syndrome.

  Recruiting Phase 1 The Children's Hospital of Zhejiang University School of Medicine · Hangzhou, Zhejiang · NCT07305116

• Second-generation CD19/BCMA CAR‑NK cell treatment for children with B cell autoimmune disease

  This study will try a new CAR‑NK cell therapy that targets CD19 and BCMA in children with B cell–driven autoimmune diseases to see if it is safe and reduces disease activity.

  Recruiting Early Phase 1 The Children's Hospital of Zhejiang University School of Medicine · Hangzhou, Zhejiang · NCT07283315

• Ultra-fast autologous CD19 CAR-T therapy for refractory systemic lupus erythematosus

  This trial will try ultra-fast autologous CD19 CAR-T cell therapy in people aged 5 and older with moderate-to-severe SLE that has not responded to high-dose steroids and multiple immunosuppressants.

  Recruiting Phase 1 The Children's Hospital of Zhejiang University School of Medicine · Hangzhou, Zhejiang · NCT07233642

• Intravenous contrast-enhanced ultrasound for diagnosing children's abdominal problems in China

  This project will try intravenous contrast-enhanced ultrasound in children (29 days–18 years) with abdominal tumors, injuries, or unexplained fluid to see if it gives clearer diagnoses.

  Recruiting The Children's Hospital of Zhejiang University School of Medicine · Hangzhou, Zhejiang · NCT07113808

• SG301 (anti-CD38) injection for children with frequently relapsing or steroid-dependent nephrotic syndrome

  This Phase 2 trial will test whether SG301 (an anti-CD38 antibody) injections are safe and help children aged 6–18 who have frequently relapsing or steroid‑dependent nephrotic syndrome.

  Recruiting Phase 2 The Children's Hospital of Zhejiang University School of Medicine · Hangzhou, Zhejiang · NCT07087314

• Effect of donor milk or formula and fortification strategies on outcomes in very preterm infants

  In very preterm babies, the study tests whether supplementing the infant's mother's milk with pasteurized donor milk or preterm formula, and using routine versus selective fortification, can improve survival without NEC and support development.

  Recruiting at 20 sites The Children's Hospital of Zhejiang University School of Medicine · Guilin, Guangxi and 23 other locations · NCT07045844

• BCMA/CD70 CAR-T therapy for treating severe lupus in children

  This study is testing a new CAR-T cell therapy to see if it can help children and young adults with severe lupus who haven't responded well to other treatments.

  Recruiting Phase 1 The Children's Hospital of Zhejiang University School of Medicine · Hangzhou, Zhejiang · NCT06934447

• Using CAR-NK cells to treat autoimmune diseases like lupus and nephrotic syndrome

  This study is testing a new treatment using CAR-NK cells to see if it can help people with autoimmune diseases like lupus and nephrotic syndrome feel better.

  Recruiting Early Phase 1 The Children's Hospital of Zhejiang University School of Medicine · Hangzhou, Zhejiang · NCT06792799

• Using blinatumomab to treat difficult cases of childhood lupus

  This study is testing if a medication called blinatumomab can help children with tough cases of lupus feel better and manage their symptoms.

  Recruiting at 2 sites Phase 1 The Children's Hospital of Zhejiang University School of Medicine · Hangzhou, Zhejiang and 1 other locations · NCT06789107

• Using stem cells from umbilical cords to treat lung disease in premature infants

  This study is testing whether using stem cells from umbilical cords can help improve lung health in premature infants with a serious lung condition called bronchopulmonary dysplasia.

  Recruiting Phase 1/2 The Children's Hospital of Zhejiang University School of Medicine · Hangzhou, Zhejiang · NCT06788470

• Using CD19 Universal CAR T Cells to Treat Severe Systemic Lupus Erythematosus

  This study is testing if a new type of CAR T cell treatment can help children with severe lupus who haven't responded to other therapies.

  Recruiting Phase 1 The Children's Hospital of Zhejiang University School of Medicine · Hangzhou, Zhejiang · NCT06691152

• Comparing two types of flexible ureteroscopes for treating kidney stones in children

  This study is testing two different sizes of flexible tools used to remove kidney stones in kids to see which one works better and is safer.

  Recruiting The Children's Hospital of Zhejiang University School of Medicine · Hangzhou, Zhejiang · NCT06628765

• Using Blinatumomab to treat children with resistant nephrotic syndrome

  This study is testing if a new drug called Blinatumomab can help children with tough-to-treat nephrotic syndrome feel better by reducing protein in their urine.

  Recruiting Phase 1 The Children's Hospital of Zhejiang University School of Medicine · Hangzhou, Zhejiang · NCT06607991

• Comparing anti-reflux stents and standard stents in children with kidney stones

  This study is testing if special anti-reflux stents can help children with kidney stones recover better and have fewer complications after surgery compared to regular stents.

  Recruiting The Children's Hospital of Zhejiang University School of Medicine · Hangzhou, Zhejiang · NCT06569173

• CAR-T cell therapy for treating multi-drug resistant nephrotic syndrome

  This study is testing a new CAR-T cell therapy to see if it can help children and adults with hard-to-treat nephrotic syndrome feel better and avoid kidney failure.

  Recruiting Phase 1 The Children's Hospital of Zhejiang University School of Medicine · Hangzhou, Zhejiang · NCT06553898

• Evaluating the safety and effectiveness of EXG110 for Fabry disease

  This study is testing a new drug called EXG110 to see if it's safe and effective for people with Fabry disease, including both adults and kids aged 7 and up.

  Recruiting at 2 sites The Children's Hospital of Zhejiang University School of Medicine · Shanghai, Shanghai Municipality and 1 other locations · NCT06539624

• Evaluating Telitacicept for Children with Nephrotic Syndrome

  This study is testing if a new treatment called telitacicept can help children with nephrotic syndrome feel better and have fewer side effects than the usual medications.

  Recruiting Phase 3 The Children's Hospital of Zhejiang University School of Medicine · Hangzhou, Zhejiang · NCT06125405

• Using Adrenocorticotropic Hormone to Treat Children with Nephrotic Syndrome

  This study is testing if adding a hormone treatment to steroids can help children with nephrotic syndrome feel better and have fewer side effects.

  Recruiting at 8 sites Phase 3 The Children's Hospital of Zhejiang University School of Medicine · Wuhan, Hubei and 7 other locations · NCT06079788

Quick answers

How many clinical trials run by The Children's Hospital of Zhejiang University School of Medicine are recruiting right now?

25, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 7, Early Phase 1: 5, Phase 3: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →